Loading clinical trials...
Loading clinical trials...
Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET): Intensive vs Liberalized Phosphate Control in Hemodialysis Recipients
Conditions
Interventions
Calcium carbonate ( Intensive phosphate control)
Calcium carbonate (Liberalized phosphate control)
Locations
5
Canada
Foothills Medical Centre
Calgary, Alberta, Canada
Capital District Health Authority
Halifax, Nova Scotia, Canada
St. Joseph's Healthcare
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Start Date
January 1, 2014
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
June 23, 2015
NCT04634916
NCT06933472
NCT07224763
NCT07033260
NCT05738525
NCT06373575
Lead Sponsor
Unity Health Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions